Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Zealand Pharma introduces new website to support people living with short bowel syndrome | ||
By: Nasdaq / GlobeNewswire - 21 Jun 2019 | Back to overview list |
|
Press release – No. 15 / 2019 Zealand Pharma introduces new website to support people living with short bowel syndrome
Copenhagen, June 21, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today launched a new website dedicated to supporting people with short bowel syndrome (SBS). The website leverages the stories and experiences of several patients and their families, as a way to focus on key aspects of living with SBS. Elements of personal insight, what to expect from available medical care and inspiration for achieving intestinal rehabilitation are intended to help SBS patients improve management of the disease for a better everyday quality of life. Medical contributors includes Professor David F. Mercer, MD, PhD, University of Nebraska Medical Center (Omaha), and Professor Kishore R. Iyer, MBBS, FRCS, the Mount Sinai Hospital (New York). These field experts provide educational disease information, including explanation of the circumstances arising from short bowel disease and available treatment options. “The rarity of SBS makes it an ‘orphan disease’. Medical expertise in SBS is in short supply, and desperate patients and their families often end up going from pillar to post, searching for expert teams. Our aim is to empower patients to talk with their medical teams, to continuously improve the treatment and management options for living with short bowel syndrome,” said Professor Kishore R. Iyer, MBBS, FRCS, from the Mount Sinai Hospital in New York. “When someone has SBS, their entire family lives and copes with the disease. We want to extend resources and support to this entire community, and LivingWithSBS.com can help as a launch point.” “Launching the new website, LivingWithSBS.com, is an ideal way to connect members of the short bowel syndrome community,” said Michael Hall, Senior Vice President of Clinical and Medical Affairs at Zealand Pharma. “The personal stories shared by people living with SBS reveal the extreme burdens of the disease, while also offering support and encouragement for other patients and their families to seek optimal management and treatment.” Visit LivingWithSBS.com to learn more about short bowel syndrome, and hear the stories from several patients and their families who successfully manage the disease in everyday life. For further information, please contact: Emmanuel Dulac, President and Chief Executive Officer Lani Pollworth Morvan, Investor Relations and Communication About short bowel syndrome (SBS) About Zealand Pharma A/S Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma. Attachment |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |